Clearwater Orthotics & Prosthetics - Medicare Supplier in Lewiston, ID

Clearwater Orthotics & Prosthetics is a medicare enrolled Prosthetic/Orthotic Supplier in Lewiston, Idaho. It is located at 801 Bryden Ave, Lewiston, Idaho 83501. You can reach out to the office of Clearwater Orthotics & Prosthetics via phone at (208) 798-4605. Clearwater Orthotics & Prosthetics supplies medicare equipments and products such as Orthoses: Prefabricated, Orthoses: Off-the-Shelf, Orthoses: Custom Fabricated, Limb Prostheses, etc. The legal business name for Clearwater Orthotics & Prosthetics is Clearwater Orthotics And Prosthetics, Llc.

Contact Information

Clearwater Orthotics & Prosthetics
801 Bryden Ave, Lewiston, Idaho 83501
(208) 798-4605


Supplier Profile

NameClearwater Orthotics & Prosthetics
Organization NameClearwater Orthotics And Prosthetics, Llc
Location801 Bryden Ave, Lewiston, Idaho 83501
TypeProsthetic/Orthotic Supplier
Phone(208) 798-4605
Participate in MedicareMedicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier.

News Archive

Scripps Research collaborates with Tempus to develop a predictive model of glucose responses

Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.

ICD-10-CM training sessions for health care professionals

Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

Advaxis' ADXS11-001 Phase 1 study for cervix cancer failures: 13.3% of treated patients alive at over 3 years

Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.

Read more Medical News

› Verified 4 days ago

Products, Equipments, Supplies available at this Supplier:

Clearwater Orthotics & Prosthetics supplies following medicare products, supplies and equipments -
  • Limb Prostheses
  • Orthoses: Custom Fabricated
  • Orthoses: Off-the-Shelf
  • Orthoses: Prefabricated

NPI Associated with this Supplier:

Suppliers may have multiple NPI numbers. We have found possible NPI number/s associated with Clearwater Orthotics & Prosthetics from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1285852004
Organization NameCLEARWATER ORTHOTICS AND PROSTHETICS, LLC
TypeProsthetic/Orthotic Supplier
Address801 Bryden Ave, Lewiston, ID 83501
Phone Number208-798-4605

News Archive

Scripps Research collaborates with Tempus to develop a predictive model of glucose responses

Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.

ICD-10-CM training sessions for health care professionals

Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

Advaxis' ADXS11-001 Phase 1 study for cervix cancer failures: 13.3% of treated patients alive at over 3 years

Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.

Read more Medical News

› Verified 4 days ago


NPI Number1699786525
Organization NameCLEARWATER ORTHOTICS & PROSTHETICS
TypeProsthetic/Orthotic Supplier
Address801 Bryden Ave, Lewiston, ID 83501
Phone Number818-357-5732

News Archive

Scripps Research collaborates with Tempus to develop a predictive model of glucose responses

Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.

ICD-10-CM training sessions for health care professionals

Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

Advaxis' ADXS11-001 Phase 1 study for cervix cancer failures: 13.3% of treated patients alive at over 3 years

Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.

Read more Medical News

› Verified 4 days ago

News Archive

Scripps Research collaborates with Tempus to develop a predictive model of glucose responses

Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.

ICD-10-CM training sessions for health care professionals

Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

Advaxis' ADXS11-001 Phase 1 study for cervix cancer failures: 13.3% of treated patients alive at over 3 years

Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.

Read more News

› Verified 4 days ago


Suppliers in Lewiston, ID

Owl Home Medical
Type: Long Term Care Pharmacy
Location: 720 16th Ave, Lewiston, Idaho 83501
Phone: (208) 743-7766    
Rite Aid Pharmacy 05408
Type: Medicare Supplier
Location: 1904 19th Ave, Lewiston, Idaho 83501
Phone: (208) 743-9127    
Walgreens #2679
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 2102 Nez Perce Dr, Lewiston, Idaho 83501
Phone: (208) 743-4434    
Sav-on Pharmacy #238
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 1024 21st St, Lewiston, Idaho 83501
Phone: (208) 743-1529    
Rosauers Pharmacy #33
Type: Pharmacy
Location: 332 Thain Rd, Lewiston, Idaho 83501
Phone: (208) 743-6511    

Medicare Suppliers

Durable Medical Equipment & Medical Supplies

Also referred to as DME Suppliers. A supplier of medical equipment such as respirators, wheelchairs, home dialysis systems, or monitoring systems, that are prescribed by a physician for a patient's use in the home and that are usable for an extended period of time.

Community/Retail Pharmacy

A pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers; administer vaccinations; and provide other professional services associated with pharmaceutical care.

Prosthetic/Orthotic Supplier

An organization that provides prosthetic and orthotic care which may include, but is not limited to, patient evaluation, prosthesis or orthosis design, fabrication, fitting and modification to treat limb loss for purposes of restoring physiological function and/or cosmesis or to treat a neuromusculoskeletal disorder or acquired condition.


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.